Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitrosoureidonucleosides.

J A Montgomery, H J Thomas

    Journal of Medicinal Chemistry
    |September 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Researchers synthesized novel nitrosourea nucleoside analogs. These compounds, designed as enzyme inhibitors, demonstrated minimal cytotoxicity and in vivo activity against leukemia L1210.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Jaborandi in the Treatment of Asthma.

    The Chicago medical journal and examiner·2023
    Same author

    Model of charge transfer collisions between C<sub>60</sub> and slow ions.

    The Journal of chemical physics·2022
    Same author

    The association between five forms of child maltreatment and depressive and anxiety disorders: A systematic review and meta-analysis.

    Child abuse & neglect·2019
    Same author

    Acute physiological responses to low-intensity blood flow restriction cycling.

    Journal of science and medicine in sport·2018
    Same author

    Recovery of chronically lame dairy cows following treatment for claw horn lesions: a randomised controlled trial.

    The Veterinary record·2016
    Same author

    Evaluation of treatments for claw horn lesions in dairy cows in a randomized controlled trial.

    Journal of dairy science·2015
    Same journal

    Novel Dual Soft Drug Strategy Enables Development of Topical Androgen Receptor Antagonists with Enhanced Efficacy and Optimized Safety for Androgenetic Alopecia.

    Journal of medicinal chemistry·2026
    Same journal

    Design, Synthesis, and Biological Evaluation of Novel PAK1/HDAC10 Dual Inhibitors That Activate Antitumor Immunity for Triple-Negative Breast Cancer Treatment.

    Journal of medicinal chemistry·2026
    Same journal

    Conformationally Tuned Cyclic RGD Peptides for Integrin-Subtype-Selective PET/CT Imaging.

    Journal of medicinal chemistry·2026
    Same journal

    RIMTAC: A Novel Degrader Design Platform by Indirect VHL-Recruitment via RIPK1.

    Journal of medicinal chemistry·2026
    Same journal

    Structure-Activity Relationship of Cycling Molecular Assemblies for Golgi Targeting and Disruption.

    Journal of medicinal chemistry·2026
    Same journal

    Rational Design of Diaryl Ether-Based Dual Inhibitors Targeting Successive Essential Enzymes HadAB and InhA in <i>Mycobacterium tuberculosis</i>.

    Journal of medicinal chemistry·2026
    See all related articles

    Area of Science:

    • Medicinal Chemistry
    • Organic Synthesis
    • Biochemistry

    Background:

    • Nucleoside analogs are crucial in developing therapeutic agents.
    • Nitrosoureas are known for their potential as anticancer drugs and enzyme inhibitors.

    Purpose of the Study:

    • To synthesize and characterize novel 3-methyl-3-nitrosoureidonucleosides and 5'-(methylnitrosoureido)deoxynucleosides.
    • To evaluate the potential of these compounds as active-site-directed irreversible enzyme inhibitors.
    • To assess their cytotoxicity and in vivo efficacy against leukemia L1210.

    Main Methods:

    • Chemical synthesis of modified ribofuranose derivatives.
    • Conversion of sugars to nucleoside analogs of adenine, cytosine, and uracil.
    • Nitrosation of methylureido nucleosides to form nitrosoureas.

    Related Experiment Videos

  • In vitro cytotoxicity assays and in vivo leukemia L1210 studies.

    • Main Results:

    • Successfully synthesized a series of 3-methyl-3-nitrosoureidonucleosides and 5'-(methylnitrosoureido)deoxynucleosides.
    • The synthesized nitrosoureas exhibited low cytotoxicity against cancer cell lines.
    • No significant in vivo activity was observed against leukemia L1210.

    Conclusions:

    • The synthesized nitrosourea nucleoside analogs are potential enzyme inhibitors.
    • Further structural modifications may be needed to enhance their therapeutic potential.
    • The compounds show limited efficacy as direct anticancer agents in the current form.